BG-75202 / BeOne Medicines - LARVOL DELTA

Second Quarter 2026 Business Highlights: Hematology (Businesswire) - "Tacabrutideg (BTK CDAC): Achieved last patient enrolled for Phase 3 CaDAnCe-303 (China-only) study (BGB-16673-303) in post-BTKi R/R CLL. BG-75202 (KAT6 A/B inhibitor): Achieved first patient enrolled into monotherapy cohort for Phase 1 study for the treatment of adult patients with acute myeloid leukemia."

Enrollment closed • Enrollment open • Acute Myelogenous Leukemia • Chronic Lymphocytic Leukemia

An Investigational Study of BG-75202 Alone and in Combination With Other Agents in Patients With Myeloid Malignancies (clinicaltrials.gov) - P1 | N=118 | Recruiting | Sponsor: BeOne Medicines | Not yet recruiting ➔ Recruiting

Enrollment open • Oncology

An Investigational Study of BG-75202 Alone and in Combination With Other Agents in Patients With Myeloid Malignancies (clinicaltrials.gov) - P1 | N=118 | Not yet recruiting | Sponsor: BeOne Medicines

New P1 trial • Oncology

An Investigational Study of BG-75202 Alone and in Combination With Other Therapeutic Agents in Adults With Advanced Solid Tumors (clinicaltrials.gov) - P1 | N=86 | Recruiting | Sponsor: BeOne Medicines | Trial completion date: Jul 2036 ➔ Jan 2037 | Trial primary completion date: Apr 2029 ➔ Sep 2029

Trial completion date • Trial primary completion date • Breast Cancer • Hormone Receptor Positive Breast Cancer • Oncology • Solid Tumor

BG-75202-101: A Phase 1a/1b Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Antitumor Activity of BG-75202, Alone and in Combination with Other Agents in Patients with Advanced Solid Tumors (clinicaltrialsregister.eu) - P1 | N=15 | Not yet recruiting | Sponsor: BeOne Medicines I GmbH

New P1 trial • Oncology • Solid Tumor

An Investigational Study of BG-75202 Alone and in Combination With Other Therapeutic Agents in Adults With Advanced Solid Tumors (clinicaltrials.gov) - P1 | N=86 | Recruiting | Sponsor: BeOne Medicines | Not yet recruiting ➔ Recruiting

Enrollment open • Breast Cancer • Hormone Receptor Positive Breast Cancer • Oncology • Solid Tumor

An Investigational Study of BG-75202 Alone and in Combination With Other Therapeutic Agents in Adults With Advanced Solid Tumors (clinicaltrials.gov) - P1 | N=86 | Not yet recruiting | Sponsor: BeOne Medicines

New P1 trial • Breast Cancer • Hormone Receptor Positive Breast Cancer • Oncology • Solid Tumor